Although the new generation mTOR inhibitors hold great promise for anticancer therapy and are rapidly moving into clinical trials, there are many important issues that determine their success in the clinic.
Although the new generation of mTOR inhibitors hold great promise for anticancer therapy and are rapidly moving into clinical trials. However, there are many important issues that determine their success in the clinic.